Pharmaceutical Diversion in Medicare. HHS Office of Inspector General: Background

Similar documents
Health Care Compliance Association Pharmaceutical Diversion in Medicare

Senior Medicare Patrol Referrals Process

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

White Collar Courier: Delivering News and Providing Guidance in White Collar Matters

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

Law Enforcement and the Prescriber Enforcement Action Protocol

The Regulatory Agency Will See You Now Kevin L. Zacharoff, MD Disclosures Nothing to Disclose

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

U.S. Department of Health and Human Services Office of Inspector General. An OIG Portfolio A

Questionable Billing and Geographic Hotspots Point to Potential Fraud and Abuse in Medicare Part D

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

What is drug diversion?

Strategies for Federal Agencies

Presentation Overview

Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Risk Classification Modeling to Combat Opioid Abuse

Case 1:13-cr SCJ-JFK Document 1 Filed 01/22/13 Page 1 of 17 SEALED ATLANTA DIVISION

Community Health Group Compliance Training. Presented by Mike Scarano, esq. Foley & Lardner

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

Update on the Opioid Crisis

FAQ: Alcohol and Drug Treatments

WEBINAR TRIBAL LAW ENFORCEMENT AND DRUG ENDANGERED CHILDREN ISSUES IN INDIAN COUNTRY

2017 NASCSA Conference

In its written comments on our draft report, CMS concurred with our recommendation.

University of Pittsburgh

DEA: Combating the Supply

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

Prescription Drug Abuse Task Force Rx Report Card

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

Tracker e-prescribing 101. The Complete Guide

Crowe Healthcare Webinar Series

ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families

DHEC Bureau of EMS DAODAS

Food and Drug Administration Office of Criminal Investigations

1025 Connecticut Avenue NW, Suite 605 * Washington, DC * (202) * Fax: (202)

Federal Firearm Prohibitions

Review of Controlled Drugs and Substances Act

Changes to the Eighth Edition

Wednesday, June 21, Dear Chairmen and Ranking Members:

Partners in a safe, drug-free campus community 2019

SEVENTH JUDICIAL CIRCUIT DRUG COURT PARTICIPANT HANDBOOK. Calhoun and Cleburne Counties

The Opioid crisis: The important role of CPAs

Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call

PRESCRIPTION MONITORING PROGRAM

FACT SHEET: Federal Parity Task Force Takes Steps to Strengthen Insurance Coverage for Mental Health and Substance Use Disorders

Statement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

Potential Solutions to Epidemic Substance Abuse in US and Europe

GILMER COUNTY SCHOOLS Policy No POLICY MANUAL

INAPPROPRIATE MEDICARE PAYMENTS FOR CHIROPRACTIC SERVICES

Perspective from Kentucky: Using PMP Data in Drug Diversion Investigations

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

THE OPIOID EPIDEMIC IN PENNSYLVANIA

Successful Prevention Strategies to Address the Opioid Crises

July 6, Dear Governor Christie:

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:

FRAUD PREVENTION IN MEDICAID. Dr. SERPIL TOKDEMIR YUCE, Ph.D. Office of Medicaid Inspector General Arkansas State USA

Safe Medication Practices

Mark W. Caverly, Chief Liaison and Policy Section

Overview of ASHP Opioid Efforts

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS (NAMSDL) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT-

Police Department City of Keene, New Hampshire. 6a/'f. Concerns Over Growing Drug Problem in Keene

COMBATING PENNSYLVANIA S OPIOID CRISIS PAID FOR BY SCOTT WAGNER FOR GOVERNOR

DEA and Doctors: Cooperation for the Public Good

The Cost of Imprisonment

Prescription Drugs: Issues in Treatment, Supervision and Case Management

High-Decile Prescribers: All Gain, No Pain?

Key Findings and Recommendations from the

Addictions 101: Understanding, Recognizing, and Treating the Disease State!

State of California Department of Justice. Bureau of Narcotic Enforcement

Physician Off-Label Marketing. FDA Regulations Governing Manufacturers

The State of Maryland Executive Department

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

MARIJUANA LEGALIZATION. INITIATIVE STATUTE.

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper

Curbing Prescription Drug Abuse in Medicaid

OVERVIEW OF STATE OPIOID POLICY AND LEGISLATION AMBER WIDGERY & ALISON LAWRENCE JUNE 2018

Pennsylvania Prescription Drug Monitoring Program Trends,

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

2/20/2019. Source: Source:

Opioid Overview Admiral Brett P. Giroir, M.D.

Your child s Medicaid program allows for routine and preventive dental visits each year. These visits help prevent dental problems and provide a

Do not open the test booklet prior to being told to do so.

Stark County Opiate Task Force

Prescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality. Brad Schimel Wisconsin Attorney General

Addiction, Pain, & Public Health website -

FY 2015 OMNIBUS SPENDING BILL

Drug and Alcohol Policy

A Bill Regular Session, 2015 SENATE BILL 717

ACCG Mental Health Summit

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Transcription:

Pharmaceutical Diversion in Medicare Office of Inspector General Office of Investigations U.S. Department of Health and Human Services HHS Office of Inspector General: Background Mission: Protect the integrity HHS programs as well as the health and welfare of program beneficiaries Fight fraud, waste, abuse in over 100 HHS programs Largest Inspector General s office in Federal Government Office of Investigations performs criminal, civil and administrative enforcement 3/24/2017 2 1

Example HHS Programs Medicare (CMS) Medicaid (CMS) Center for Disease Control (CDC) Indian Health Services (IHS) National Institutes of Health (NIH) Substance Abuse & Mental Health Services Admin (SAMHSA) Agency for Healthcare Research and Quality (AHRQ) Food and Drug Administration (FDA) 3 HHS/OIG: Components Office of Evaluations & Inspections: Conducts and publishes studies on various vulnerabilities in Medicare/Medicaid. Reports on OIG website with recommendations. Several drug related reports. Office of Audit: Conducts independent audits of HHS programs/grantees. Also create reports and make recommendations. Office of Council to IG: Provides legal counsel to IG and other components. Performs civil monetary penalties, provider self disclosures, collaborates with DOJ on national cases, provide advisory opinions to industry. Office of Management and Policy: Provides mission and administrative support to the OIG. Data analytic unit. Office of Investigations: Law enforcement arm of OIG. Traditional law enforcement techniques with contemporary data analytic tools to identify trends and targets for investigations and prosecution 3/24/2017 4 2

OIG Collaborative Effort Tactical Diversion Squads (with DEA) Strike Force Units (FBI on HEAT initiative) With state, local LE Use/encourage Prescription Drug Monitoring Programs (PDMP) Support education of industry, patients, providers, pharmacists - Can t prosecute our way out of this problem 3/24/2017 5 HHS/OIG: Results Over the last 5 years: 4,478 Criminal Actions 2,762 Civil Actions 18,109 Exclusions $21.9 Billion in Monetary results Since 1997 - $31 Billion returned to the Medicare Trust Fund Over last 3 years: $5 to $1 return on Investment 3/24/2017 6 3

Exclusion Authorities Social Security Act (Sections 1128 and 1156) Approximately 3000 actions per year Duration from 3 years to Permanent 47% Based on License Revocation/Suspension/Surrender 48% Based on Convictions Health Care Fraud or other Program Related Offense, Patient Abuse/Neglect, Controlled Substance Covers Medicare, Medicaid, Tricare, federal w/c, SCHIP, VA, and IHS (home mortgages, student loans) 3/24/2017 7 Recent OIG Drug Reports Inappropriate Medicare Part D Payments for Schedule II Drugs Billed as Refills $25M Prescribers with Questionable Patterns in Medicare Part D 736 general care physicians Retail Pharmacies with Questionable Part D Billing Over 2600 pharmacies identified Medicare Inappropriately Paid for Drugs Ordered by Individuals Without Prescribing Authority Massage Therapists, Athletic Trainers, Home Repair Contractors, etc. 3/24/2017 8 4

2015 OEI Report 9 Newest OEI Report 10 5

Spending for Part D Drugs 2006-2015 $137 $121 $104 Spdnding in BIllions $51 $62 $68 $74 $78 $85 $90 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 11 Commonly Abused Opioids 12 6

Part D Breakdown $8.4 B spent on controlled drugs (6%) $129 B spent on non-controlled drugs Predicted to double by 2023 13 Different Drug Jurisdictions DEA: Controlled substance laws and regulations of the United States HHS/OIG: Pharmaceuticals billed to federal healthcare programs Those paid by Medicare, Medicaid Includes Controlled Substances paid by federal programs But also includes Non-Controlled Substances 3/24/2017 14 7

DEA & HHS/OIG Authority 3/24/2017 15 Why Divert Non-Controlled? Controlled Drugs: Diverted for recreational use $100+B in societal costs Non-Controlled: 1. High reimbursement financial crime. Not dispensed, just billed. Not government money 2. Some diverted to other countries 3. Others mixed into streetcocktailswith controlled substances; are POTENTIATORS 3/24/2017 16 8

Potentiators Drug recipes that aggregate drugs that in combination enhance the euphoria May be another controlled drug but often are noncontrolled drugs (OIG purview) Pushes patients over edge to respiratory arrest/death Hundreds of potentiatorsin thousands of combinations Large financial exposure to Medicare program 17 New Paradigms for Death Extraction methods for pure product Heavy use with potentiators (Mixed Drug Ingestions) New portals of entry (anywhere there is a good vascular bed) to avoid first-pass effect 18 9

Drug Blogs Erowid.org Bluelight.org Drugs-Forum.com Opiophile.org 19 Erowid Recipe Blog Well, after that last entry I just kind of passed out. I remember seeing something out of the corner of my eyes and trying to grab for it but never actually catching it. Once I passed out I was GONE, people tried to wake me and I was completely unresponsive, they almost called 911 but decided against when they could see I was still breathing. So yea I am going to do it again pretty soon probably.. 20 10

How to Prepare IV Opana 21 Zohydro Abuse 22 11

Polypharmacy Cocktails Potentiators Abilify + Seroquel Snort ( jailhouse heroin ) Soma + Codeine ( Soma Coma ) Seroquel + Zyprexa + Ativan + ETOH + Cocaine HIV Protease Inhibitors + Percocet Caffeine + ETOH + Eyeball 3/24/2017 23 Polypharmacy Cocktails Potentiators Promethazine/Codeine + Tampon ETOH + Albuterol Inhaler Adderall + Albuterol + Sleep deprivation Adderall + Lexapro + Cannabis 24 12

TJA(5 Prescription Drug Fraud A physician wrote illegal prescriptions for co-conspirator patients more than 700,000 pills passed along to 6 different drug trafficking organizations. Norman Werther along with 61 associates received a combined 253 years in prison. Dr. Werther received 20 years and ordered to forfeit $10 million. Inside Pharmacy 26 13

Slide 25 TJA(5 Double check this photo. This, as well as several other slides, came from presentations I have created in the past and I believe there was a problem with the Werther photo. Unfortunately the link is archived so I can't double check it. Trussell, Jennifer A (OIG/OI), 1/18/2017

TJA(5 Prescription Drug Fraud January 2016, Jaime Guerrero admitted to distributing and dispensing Schedule II and III controlled substances to patients without a legitimate medical purpose beyond the bounds of professional medical practice resulting in patient death. Case Example Jaime Guerrero, a medical physician with offices in Louisville, Kentucky, and Jeffersonville, Indiana. Charged in a 32 count indictment with unlawfully dispensing pain medications to 30 patients, without a legitimate medical purpose and beyond the bounds of professional medical practice. Allegedly prescribed pain medications that resulted in the deaths of five patients. 28 14

Slide 27 TJA(5 Double check this photo. This, as well as several other slides, came from presentations I have created in the past and I believe there was a problem with the Werther photo. Unfortunately the link is archived so I can't double check it. Trussell, Jennifer A (OIG/OI), 1/18/2017

Case Example He saw more than 100 patients on each of the dates, by himself, and spent approximately 3 minutes or less with each patient, and fraudulently billed various health care benefit programs, for office visits at a higher code than the service provided. He travelled outside of the United States and directed staff personnel to provide group counseling sessions for patients in his absence. The group sessions were then billed as individual counseling sessions, and as if Guerrero personally provided the service. 29 Case Example Department of Justice U.S. Attorney s Office Western District of Kentucky FOR IMMEDIATE RELEASE Thursday, May 12, 2016 KentuckianaAnesthesiologist Sentenced To 100 Months For Unlawful Distribution Of Controlled Substances, Health Care Fraud, Conspiracy, And Money Laundering 30 15

What To Do if you Suspect Fraud or Diversion Activity? Use available databases to scrutinize scripts; including your state PDMP database If receive a clearly fraudulent script, forged script, ID theft; engage law enforcement immediately If you suspect a Medicare provider or beneficiary is diverting, contact 800-HHS-TIPS or at oig.hhs.gov/report-fraud 3/24/2017 31 Thank You 16